Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Treatment of Schamberg's disease with pentoxifylline: Therapeutic trial
Ist Teil von
Indian journal of dermatology, venereology, and leprology, 2003, Vol.69 (1), p.25-26
Ort / Verlag
New Delhi: Indian Association of Dermatologists, Venereologists and Leprologists
Erscheinungsjahr
2003
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
Twenty patients with Schamberg's disease were started on pentoxifylline (400 mg once daily) for a period of 8 weeks. Improvement was assessed at 2 weekly intervals by two observers independently and graded as mild (< 25%, moderate (25-50%) and marked (>50%). Marked improvement was observed in 10/20(50%) patients. We conclude that pentoxifylline should be considered as first line therapy in all patients with Schamberg's disease.